RemediumOne at GPHS 2025 – Driving Innovation in Vector – Borne Disease Prevention

RemediumOne is proud to have successfully managed a groundbreaking clinical trial showcased during the symposium “Developing Tools for Prevention and Control of Aedes-Borne Viruses (ABV) Through Innovation”, held on 16th July 2025 at Hilton Residences, Colombo, as part of the Global Public Health Summit (GPHS) 2025. The Global Public Health Summit 2025 & 30th CCPSL Annual Academic Sessions is a leading international forum uniting public health experts, policymakers, researchers, and global leaders to tackle key health issues in resource-limited settings.
This engaging session brought together global experts and thought leaders in vector control, social science, and epidemiology to discuss innovative strategies to combat Aedes-borne viruses.

Highlights from the Symposium:

Theme: Developing Tools for Prevention and Control of ABV Through Innovation
Co-chaired by: Dr. Hasitha Tissera, Epidemiology Unit, Ministry of Health and Prof. John Grieco, University of Notre Dame
Key Presentations:
Innovative Vector Control Approaches for Dengue Prevention – Prof. Nicole Achee
Cluster Randomized Placebo-Controlled Community Trial on Spatial Repellent in Gampaha, Sri Lanka: Challenges and Solutions – Dr. Anoja Dheerasinghe
The Role of Social Science in the Spatial Repellent Study in Sri Lanka – Dr. Steven Harvey

Expert Panelists:

Dr. Amy Morrison

Field Director
Department of Entomology and Nematology
NMRCD Iquitos Laboratory
University of California, Davis

Prof. Neelika Malavige

Professor
Department of Immunology and Molecular Medicine, University of Sri Jayewardenepura, Sri Lanka

Dr. Bobby Reiner

Professor of Health Metrics Sciences and the Institute for Health Metrics and Evaluation
Schools of Medicine at the University of Washington

Prof. Nicole Achee

Medical Entomologist
Research Professor
Department of Biological Sciences
University of Notre Dame

Dr. Anoja Dheerasinghe

Consultant Community Physician
National Dengue Control Unit

Dr. Steven Harvey

Associate Professor
Johns Hopkins Bloomberg School of Public Health, Baltimore

This symposium highlighted how community-based trials, global collaborations, and innovation in vector control can pave the way for effective prevention strategies against dengue and other Aedes-borne viruses.

We at RemediumOne are proud to be at the forefront of managing large-scale, high-impact clinical research in Sri Lanka, contributing to global health solutions through innovation and collaboration.